Estimation of the Share of Net Expenditures on Insulin Captured by US Manufacturers, Wholesalers, Pharmacy Benefit Managers, Pharmacies, and Health Plans From 2014 to 2018

IMPORTANCE: Recent US media and policy attention on insulin affordability has focused on the role of manufacturers in setting prices; however, the role of other drug distribution intermediaries in determining prices has received less attention. OBJECTIVE: To estimate the share of net expenditures on...

Descripción completa

Detalles Bibliográficos
Autores principales: Van Nuys, Karen, Ribero, Rocio, Ryan, Martha, Sood, Neeraj
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2021
Materias:
Original Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796876/
https://www.ncbi.nlm.nih.gov/pubmed/35977268
http://dx.doi.org/10.1001/jamahealthforum.2021.3409

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8796876/
https://www.ncbi.nlm.nih.gov/pubmed/35977268
http://dx.doi.org/10.1001/jamahealthforum.2021.3409

Ejemplares similares